Clinical Trials Browser

Phase 2 × Recruiting × Respiratory Syncytial Virus Infections × Clear all

NCT06817889 2026-02-27

Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals

Phase 2 Recruiting

Autoimmune Diseases, Respiratory Syncytial Virus Infections

NCT06597916 2024-11-27

RSV Vaccination in Immunocompromised Patients.

Phase 2 Recruiting

Respiratory Syncytial Virus Infections